Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation.

Jenkins RW, Oxnard GR, Elkin S, Sullivan EK, Carter JL, Barbie DA.

Clin Lung Cancer. 2015 Sep;16(5):e101-4. doi: 10.1016/j.cllc.2015.01.009. Epub 2015 Feb 7. No abstract available.

2.

Pickled egg production: effect of brine acetic acid concentration and packing conditions on acidification rate.

Acosta O, Gao X, Sullivan EK, Padilla-Zakour OI.

J Food Prot. 2014 May;77(5):788-95. doi: 10.4315/0362-028X.JFP-13-362.

PMID:
24780334
3.

Pickled egg production: inactivation rate of Salmonella, Escherichia coli O157:H7, Listeria monocytogenes, and Staphylococcus aureus during acidification step.

Sullivan EK, Manns DC, Churey JJ, Worobo RW, Padilla-Zakour OI.

J Food Prot. 2013 Nov;76(11):1846-53. doi: 10.4315/0362-028X.JFP-13-132.

PMID:
24215686
4.

Evaluation of a flexible collagen surgical patch for reinforcement of a fascial defect: Experimental study in a sheep model.

Sullivan EK, Kamstock DA, Turner AS, Goldman SM, Kronengold RT.

J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):88-94. doi: 10.1002/jbm.b.31073.

PMID:
18335439
6.

Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy.

Lewis RA, Katz GJ, Weiss MJ, Landry TA, Dickerson JE, James JE, Hua SY, Sullivan EK, Montgomery DB, Wells DT, Bergamini MV; Travoprost BAC-free Study Group.

J Glaucoma. 2007 Jan;16(1):98-103.

PMID:
17224758
7.

The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.

Whitson JT, Ochsner KI, Moster MR, Sullivan EK, Andrew RM, Silver LH, Wells DT, James JE, Bosworth CF, Dickerson JE, Landry TA, Bergamini MV; Brimonidine 0.15% Study Group.

Ophthalmology. 2006 Aug;113(8):1333-9.

PMID:
16877072
8.

Mechanical effects of high density polyethylene dynamic compression plate hole inserts on bone-plate constructs.

Sullivan EK, Nunamaker DM, Richardson DW.

Vet Comp Orthop Traumatol. 2005;18(2):63-6.

PMID:
16594199
9.

Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.

Slakter JS, Bochow TW, D'Amico DJ, Marks B, Jerdan J, Sullivan EK, Robertson SM, Slakter JS, Sullins G, Zilliox P; Anecortave Acetate Clinical Study Group.

Ophthalmology. 2006 Jan;113(1):3-13. Epub 2005 Dec 20.

PMID:
16368146
10.

Trichophytobezoar duodenal obstruction in New World camelids.

Sullivan EK, Callan RJ, Holt TN, Van Metre DC.

Vet Surg. 2005 Sep-Oct;34(5):524-9.

PMID:
16266347
11.

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM.

Am J Ophthalmol. 2005 Aug;140(2):242-50.

PMID:
16086946
12.

The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.

Kim J, Dally LG, Ederer F, Gaasterland DE, VanVeldhuisen PC, Blackwell B, Sullivan EK, Prum B, Shafranov G, Beck A, Spaeth GL; AGIS Investigators.

Ophthalmology. 2004 Nov;111(11):2109-16.

PMID:
15522379
13.

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension.

Netland PA, Robertson SM, Sullivan EK, Silver L, Bergamini MV, Krueger S, Weiner AL, Davis AA; Travoprost Study Groups.

Adv Ther. 2003 May-Jun;20(3):149-63.

PMID:
12956257
14.

Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.

Orsini JA, Haddock M, Stine L, Sullivan EK, Rabuffo TS, Smith G.

J Am Vet Med Assoc. 2003 Aug 1;223(3):336-9.

PMID:
12906229
15.

Disorders of the pharynx.

Sullivan EK, Parente EJ.

Vet Clin North Am Equine Pract. 2003 Apr;19(1):159-67, vii-viii. Review.

PMID:
12747666
16.

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group.

Retina. 2003 Feb;23(1):14-23.

PMID:
12652226
17.

Use of a pool-raft system for recovery of horses from general anesthesia: 393 horses (1984-2000).

Sullivan EK, Klein LV, Richardson DW, Ross MW, Orsini JA, Nunamaker DM.

J Am Vet Med Assoc. 2002 Oct 1;221(7):1014-8.

PMID:
12369680
18.

Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.

Hellberg MR, McLaughlin MA, Sharif NA, DeSantis L, Dean TR, Kyba EP, Bishop JE, Klimko PG, Zinke PW, Selliah RD, Barnes G, DeFaller J, Kothe A, Landry T, Sullivan EK, Andrew R, Davis AA, Silver L, Bergamini MV, Robertson S, Weiner AL, Sallee VL.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S13-33.

PMID:
12204698
19.

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA; Travoprost Study Group.

Ophthalmology. 2002 May;109(5):998-1008.

PMID:
11986110
20.

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.

Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK; International Travoprost Study Group.

J Glaucoma. 2001 Oct;10(5):414-22.

PMID:
11711841
21.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Oct;132(4):472-84.

PMID:
11589866
24.

Transcriptional activation domains of human heat shock factor 1 recruit human SWI/SNF.

Sullivan EK, Weirich CS, Guyon JR, Sif S, Kingston RE.

Mol Cell Biol. 2001 Sep;21(17):5826-37.

25.

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE; North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Transplantation. 2001 Apr 27;71(8):1065-8.

PMID:
11374404
27.
28.

Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study.

Furth SL, Donaldson LA, Sullivan EK, Watkins SL; North American Pediatric Renal Transplant Cooperative Study.

Pediatr Nephrol. 2000 Dec;15(3-4):179-82.

PMID:
11214588
29.

Stability of a human SWI-SNF remodeled nucleosomal array.

Guyon JR, Narlikar GJ, Sullivan EK, Kingston RE.

Mol Cell Biol. 2001 Feb;21(4):1132-44.

30.

The impact of recombinant human growth hormone treatment on final adult height.

Fine RN, Sullivan EK, Tejani A.

Pediatr Nephrol. 2000 Jul;14(7):679-81. Review.

PMID:
10912542
31.

The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients.

Fine RN, Sullivan EK, Kuntze J, Blethen S, Kohaut E.

J Pediatr. 2000 Mar;136(3):376-82.

PMID:
10700696
32.
33.

Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study.

Lerner GR, Warady BA, Sullivan EK, Alexander SR.

Pediatr Nephrol. 1999 Jun;13(5):404-17.

PMID:
10412861
34.

The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A.

Pediatr Transplant. 1999 May;3(2):152-67.

PMID:
10389139
35.
36.

ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB).

Osorio AV, Sullivan EK, Alexander SR, Bryan CF, Shield CF, Warady BA.

Pediatr Transplant. 1998 Feb;2(1):26-9.

PMID:
10084756
37.
39.
41.

The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after initial trabeculectomy.

Schwartz AL, Van Veldhuisen PC, Gaasterland DE, Ederer F, Sullivan EK, Cyrlin MN.

Am J Ophthalmol. 1999 Jan;127(1):8-19.

PMID:
9932993
42.

Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study.

Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld L, Kohaut E, Fine R.

Pediatr Nephrol. 1998 May;12(4):328-37.

PMID:
9655366
43.

Cytomegalovirus infections following renal transplantation--effects on antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study.

Bock GH, Sullivan EK, Miller D, Gimon D, Alexander S, Ellis E, Elshihabi I.

Pediatr Nephrol. 1997 Dec;11(6):665-71.

PMID:
9438638
44.

Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Furth SL, Sullivan EK, Neu AM, Tejani A, Fivush BA.

Pediatr Transplant. 1997 Aug;1(1):37-42.

PMID:
10084785
45.
46.

Immunization practices in children with renal disease: a report of the North American Pediatric Renal Transplant Cooperative Study.

Furth SL, Neu AM, Sullivan EK, Gensler G, Tejani A, Fivush BA.

Pediatr Nephrol. 1997 Aug;11(4):443-6.

PMID:
9260242
49.

Pediatric renal transplantation--the NAPRTCS experience.

Tejani AH, Sullivan EK, Harmon WE, Fine RN, Kohaut E, Emmett L, Alexander SR.

Clin Transpl. 1997:87-100.

PMID:
9919393
50.

Factors that impact on the outcome of second renal transplants in children.

Tejani A, Sullivan EK.

Transplantation. 1996 Sep 15;62(5):606-11.

PMID:
8830823

Supplemental Content

Loading ...
Support Center